Article
A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency
27 Nov 2024
Abstract excerpt
CONTEXT: Pegpesen is a novel Y-shape pegylated recombinant human growth hormone (rhGH) for once-weekly treatment of children with growth hormone deficiency (GHD). OBJECTIVE: This work aimed to evaluate the efficacy and safety of Pegpesen in children with GHD vs daily rhGH. METHODS: A multicenter, randomized, controlled phase 3 clinical trial was conducted at 23 centers in China with a duration of 52 weeks'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
